Global Approvals Analysis: Eight Brain Device Approvals Mark Neurotech November
Executive Summary
Medtech Insight's Approvals Tracker reports 22 medical device approvals from outside the United States in November, including 12 CE marks from Europe, plus approvals from Taiwan, Singapore, Japan, India, Canada, Australia and Argentina.
You may also be interested in...
Device-Activated Drugs, An Old Dog With Some New Tricks
As technologies move from the lab to commercialization, changes to them need to be made to make them financially and practically appropriate for clinical settings. In Vivo spoke to two companies pioneering new types of device-activated drugs to learn about these changes and how the end products will help patients.
Device-Activated Drugs, An Old Dog With Some New Tricks
As technologies move from the lab to commercialization, changes to them need to be made to make them financially and practically appropriate for clinical settings. Medtech Insight spoke to two companies pioneering new types of device-activated drugs to learn about these changes and how the end products will help patients.
Minute Insight: SonALAsense MR-Guided Ultrasound Drug-Device Combo Trials Get Green Light
SonALAsense has received Safe to Proceed letters from the FDA to begin trials of its ultrasound-activated cancer killing drug.